Policosanol safely down-regulates HMG-CoA reductase – potential as a component of the Esselstyn regimen-Reference-Cited by-同舟云学术

Policosanol safely down-regulates HMG-CoA reductase – potential as a component of the Esselstyn regimen

Published:2002-09 Issue:3 Volume:59 Page:268-279
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

McCarty M.F

Publisher

Elsevier BV

Subject

General Medicine

Reference169 articles.

1. Anonymous., Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383–1389

2. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group;Shepherd;N. Engl. J. Med.,1995

3. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators;Sacks;N. Engl. J. Med.,1996

4. Can the clinical efficacy of the HMG CoA reductase inhibit effects on LDL-cholesterol?;Gaw;Atherosclerosis,1996

5. Statins do more than just lower cholesterol;Vaughan;Lancet,1996

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A 8-week, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Saccharum officinarum wax alcohols (Policosanol) on improvement of blood cholesterol;Journal of King Saud University - Science;2023-08

2. The Current Status of Research on High-Density Lipoproteins (HDL): A Paradigm Shift from HDL Quantity to HDL Quality and HDL Functionality;International Journal of Molecular Sciences;2022-04-02

3. Study on the Efficacy and Safety of Policosanol in the Treatment of Senile and Elderly Patients with Hyperlipidemia;Indian Journal of Pharmaceutical Sciences;2021

4. Enhancement of HDL by Policosanol;High-Density Lipoproteins as Biomarkers and Therapeutic Tools;2019

5. Long-Term Consumption of Cuban Policosanol Lowers Central and Brachial Blood Pressure and Improves Lipid Profile With Enhancement of Lipoprotein Properties in Healthy Korean Participants;Frontiers in Physiology;2018-04-24